1. Home
  2. MIDD vs MMED Comparison

MIDD vs MMED Comparison

Compare MIDD & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

HOLD

Current Price

$138.78

Market Cap

6.1B

Sector

Industrials

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$18.99

Market Cap

5.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIDD
MMED
Founded
1888
1983
Country
United States
United States
Employees
N/A
2800
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.1B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
MIDD
MMED
Price
$138.78
$18.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$180.13
$22.56
AVG Volume (30 Days)
506.4K
1.1M
Earning Date
05-08-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,201,202,000.00
N/A
Revenue This Year
$5.87
$15.99
Revenue Next Year
$3.22
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$110.82
$10.65
52 Week High
$180.13
$19.19

Technical Indicators

Market Signals
Indicator
MIDD
MMED
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
MIDD
MMED

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in the foodservice industry. The company develops and manufactures a broad line of solutions used in commercial foodservice and food processing. The group showcases its solutions in the Middleby Innovation Kitchens for commercial foodservice and industrial baking and protein Innovation Centers for food processing solutions.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: